Company Filing History:
Years Active: 2021-2024
Title: Ki Yoon Kim: Innovator in Gene and Cell Therapy
Introduction
Ki Yoon Kim is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the fields of gene and cell therapy, holding a total of 5 patents. His innovative work focuses on utilizing advanced technologies to address critical health issues.
Latest Patents
One of his latest patents involves gene and cell therapy using cell fusion technology. This invention relates to the use of cells that overexpress hemagglutinin neuraminidase (HN) and fusion (F) proteins. These proteins enhance cell fusion with other cells, restore damaged cells, and facilitate the transfer of normal genes. The clinical application of this technology is expected to reduce damage in neurodegenerative and muscular diseases through effective cell fusion.
Another significant patent by Ki Yoon Kim is the use of miR-18b for the prevention, treatment, or diagnosis of muscle diseases and neuromuscular diseases. His research confirmed that gene mutations can reduce miR-18b expression, leading to dysregulation of signaling pathways that induce calcium signaling, cell differentiation inhibition, and apoptosis. This discovery positions miR-18b as a potential target for diagnosing and treating muscle diseases caused by gene mutations, such as ALS and DMD.
Career Highlights
Ki Yoon Kim has worked with notable companies, including Curamys Inc. and Curamys Co., Ltd. His career reflects a commitment to advancing medical science through innovative research and development.
Collaborations
Throughout his career, Ki Yoon Kim has collaborated with esteemed colleagues, including Jung-Joon Sung and Seung-Yong Seong. These partnerships have contributed to the success of his research and the development of his patents.
Conclusion
Ki Yoon Kim is a distinguished inventor whose work in gene and cell therapy has the potential to transform treatment options for various diseases. His innovative patents and collaborations highlight his dedication to advancing medical science and improving patient outcomes.